NASDAQ
EXC
Last Price
US $46.62
KEY FIGURES
MKT CAP
$48.5B
EPS
TTM
$2.71
PEG
TTM
9.31x
P/E
TTM
17.30x
P/S
TTM
2.00x
YIELD
3.46%
GROWTH
Revenue Y/Y
Valuation
Financial
Performance
Financial risk - Cash flow debt coverage.
Exelon Corporation cash flow to debt ratio of 12.37% indicates that the company cannot generate enough cash to cover its debt over time. This level indicates weak financial health.
Financial risk - Healthy cash flow growth.
Exelon Corporation's free cash flow has decreased 48.89% from $-1.53G last year to $-2.27G, signaling decreasing performance
Financial risk - Healthy debt to equity ratio.
Exelon Corporation's debt to equity ratio is 1.76, which means that the company's assets are unhealthy financed, signaling financial risk. READ MORE: A ratio over 0.60 means the company finances its assets with debt, signaling financial risk. If ratio is negative, the company spent its own equity and risks bankruptcy
Financial risk - Healthy debt to equity ratio development.
Exelon Corporation's debt has increased relative to shareholder equity from 1.73 last year to 1.76 today, signaling weakened financials
Financial risk - Net debt/EBITDA.
Exelon Corporation has a net debt to EBITDA ratio of 5.45x, which exceeds the 3.00x threshold, indicating high leverage and potential financial risk
Financial stability - ICR.
Exelon Corporation's interest coverage ratio of 2.40 indicates that earnings with margin can cover interest payments on company debt
Financial stability - Profit margin growth.
Exelon Corporation's profit margin has increased (4.96%) in the last year from 10.68% to 11.21%, signaling increasing performance
Financial risk - Short term assets vs short term liabilities.
Exelon Corporation's short-term liabilities of $10.33G exceed its short-term assets of $9.55G, signaling financial risk
Decreasing performance - ROA.
Exelon Corporation's return on assets of 2.36% is lower than the 5.00% threshold, indicating inefficient asset utilization
Decreasing performance - Absolute return on equity.
Exelon Corporation's return on equity of 9.76%, is lower than 15.00%, indicating bad performance
Increasing performance - Earnings quality.
Exelon Corporation's operating cash flow exceeds its net income, indicating high-quality earnings backed by actual cash generation
Increasing performance - Earnings stability.
Exelon Corporation had positive net income in 5.00 out of 5 years, indicating stable and consistent earnings
Decreasing performance - Free cash flow.
Exelon Corporation has negative free cash flow, indicating the company is burning cash rather than generating it
Decreasing performance - FCF yield.
Exelon Corporation has negative free cash flow, indicating cash burn
Increasing performance - Healthy earnings growth.
Exelon Corporation's yearly earnings has increased 12.52% since last year from $2.46G to $2.77G, signaling increasing performance
Increasing performance - Healthy revenue growth.
Exelon Corporation's yearly revenue has increased 5.34% since last year from $23.03G to $24.26G, signaling increasing performance
Decreasing performance - ROIC.
ROIC 3.91% (Source: FMP key-metrics). Below the 5% partial-credit threshold. Score: 0 of 2. The 5% and 10% cutoffs anchor to typical US weighted-average cost of capital. Below 5% indicates the company is not generating returns above its likely cost of capital under this definition of invested capital. Invested capital here includes equity, non-current liabilities (pension obligations, deferred taxes, lease obligations), and short-term debt. Cash is not subtracted. Companies with substantial float, lease portfolios, or cash holdings will score lower under this definition than under narrower operating-capital definitions. See methodology.
Increasing performance - 3-year revenue CAGR.
Exelon Corporation's 3-year revenue CAGR of 8.34% is positive, indicating growing revenue over the past 3 years
Increasing performance - Revenue consistency.
Exelon Corporation had revenue growth in 4.00 out of 5 years, indicating consistent revenue performance
Increasing performance - ROE consistency.
Exelon Corporation had positive ROE in 5.00 out of 5 years, indicating consistent and reliable returns on equity
Overvalued - DCF valuation.
Exelon Corporation has insufficient data to evaluate this check.
Undervalued - Earnings yield.
Exelon Corporation has an earnings yield of 5.73%, which is above the 4.00% threshold, indicating the stock offers reasonable value relative to its earnings
Overvalued - EBITDA valuation.
Exelon Corporation is overvalued relative to its fair value price of 11.84 based on EBITDA multiple model
Undervalued - EV/EBITDA.
Exelon Corporation has an EV/EBITDA ratio of 11.06x, which is below the 20.00x threshold, indicating reasonable valuation relative to its operating earnings
Overvalued - PEG ratio value.
Exelon Corporation has a PEG-ratio over 1 which is considered overvalued
Undervalued - P/B ratio.
Exelon Corporation has a price-to-book ratio of 1.66x, which is below the 5.00x threshold, indicating reasonable valuation relative to its book value
Undervalued - P/S ratio.
Exelon Corporation has a price-to-sales ratio of 1.96x, which is below the 8.00x threshold, indicating reasonable valuation relative to its revenue
Profit margin
Current Ratio
Capital Returns
9.76%
Return on equity
ROIC: 3.91%
Valuation History
17.3X
Price to Earnings
EV/EBITDA: 11.1X
Cash flow
Profit margin
-5.99%
(FY vs FY)
EBITDA Y/Y
-2.90%
(FY vs FY)
Cash flow Y/Y
10.88%
(FY vs FY)
Cash Flow (DCF)
Fair Value
Market $46.62
—
Default assumptions
EBITDA Multiple
Fair Value
Market $46.62
-74.60%
Default assumptions
Base valuations use default assumptions. Customize in the Valuator.